跳至主要内容
临床试验/NCT06344832
NCT06344832尚未招募不适用

Somatostatin Receptor Antagonist PET/CT for Pre-operative N Stage Evaluation in Patients With Gastro-entero-pancreatic Neuroendocrine Tumors

Peking Union Medical College Hospital0 个研究点目标入组 40 人开始时间: 2024年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40
主要终点
lymph node metastasis status

研究概览

简要总结

The research aims to prospectively include patients with GEP-NENs, undergo preoperative imaging assessment (including PET/CT and contrast-enhanced CT), and accurately delineate lymph node regions. Through postoperative pathological reports, the diagnostic performance of lymph node metastasis (LNM) in GEP-NENs is evaluated. Factors influencing the diagnostic accuracy of SSTR-PET/CT and contrast-enhanced CT are also investigated.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old;
  • Patients diagnosed with GEP-NEN by surgical pathology;
  • Complete medical records including basic information and treatment process;
  • Patients who have undergone preoperative contrast-enhanced CT and 68Ga-SSTR-PET/CT, and have consented to the 68Ga-SSTR-PET/CT project in the Nuclear Medicine Department.

排除标准

  • Presence of concomitant malignancies;
  • Cases diagnosed pathologically as non-GEP-NEN.

结局指标

主要结局

lymph node metastasis status

时间窗: 2024.04.01~2030.03.01

lymph node metastasis status confirmed by histopathology

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验